Globally: 207 million
(uncertainty range: 135 – 287 million)
Globally: 627 000
(uncertainty range: 473 000 – 789 000)
90% of all malaria deaths occur in sub-Saharan Africa
and 77% occur in children under five
Population at risk
3.4 billion (half of the world population)
In 2013, 97 countries had on-going malaria transmission.
80% of estimated malaria deaths occur in 18 most affected countries.
About 40% of malaria deaths occur in just two countries: Nigeria and the Democratic Republic of the Congo
The malaria mortality rate was reduced in 2000 - 2012 Globally: by 45% in WHO African Region: by 49 %
52 countries are on track to reduce their malaria case incidence rates by 75%, in line with World Health Assembly and Roll Back Malaria targets for 2015. These 52 countries only account for 4% (8 million) of the total estimated malaria cases. 59 countries are on track to meet the Millennium Development Goal target of reversing the incidence of malaria (between 2000 and 2015).
Between 2000 and 2012, an estimated 3.3 million lives were saved as a result of a scale-up of malaria interventions.
90%, or 3 million, of these lives saved are in the under-five age group, in sub-Saharan Africa.
Required health expenditure
US$ 5.1 billion is needed every year
In 2012, the global total of international and domestic funding for malaria was US$ 2.5 billion – less than half of what is needed.
Direct: USD 12 billion per year in direct losses,
lost 1.3% of GDP growth per year for Africa.
Current level of coverage
Treatment: In 2012, 331 million ACT courses were procured by the public and private sectors in endemic countries – up from 278 million in 2011, and just 11 million in 2005. Nets: in 2013, an estimated 136 million long-lasting insecticidal nets (LLINs) were delivered to endemic countries, a major increase over the 70 million bed nets that were delivered in 2012. IRS (indoor residual spraying): in 2012, 135 million people (4% of the global population at risk of malaria) were protected by indoor residual spraying worldwide. Diagnostics: The volume of RDT sales to the public and private sectors of endemic countries has increased from 88 million in 2010 to 205 million in 2012. The number of patients tested by microscopic examination increased to 188 million in 2012, with India accounting for over 120 million slide examinations.
MDGs that could be impacted by addressing malaria problem
MDG 1 - Eradicating extreme poverty and hunger MDG 2 - Achieve universal primary education MDG 4 - Reduce child mortality MDG 5 - Improve maternal health MDG 6 - Combat HIV/AIDS, malaria and other diseases MDG 8 - global partnerships for development and access to affordable drugs
Costs of interventions
Long-lasting insecticidal net that lasts three years: US$ 1.39 per person per year of protection Course of artemisinin-based combination therapy (ACT) for an adult: US$ 0.90 - 1.40 Course of artemisinin-based combination therapy (ACT) for a young child: US$ 0.30 - 0.40 Rapid diagnostic test: US$ 0.50